Cargando…
Empirical antifungal treatment in the critically ill patients: how does it impact on the outcome?
Autores principales: | Bruyère, R, Vigneron, C, Quenot, J, Hamet, M, Dalle, F, Prin, S, Charles, PE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363465/ http://dx.doi.org/10.1186/cc10654 |
Ejemplares similares
-
Procalcitonin has a poor prognosis value in critically ill patients with candidemia
por: Charles, PE, et al.
Publicado: (2012) -
Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
por: Bruyère, Rémi, et al.
Publicado: (2014) -
Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study
por: Bruyere, Rémi, et al.
Publicado: (2014) -
Dysmagnesaemia and Critical Illness Outcomes
por: Homer, LE, et al.
Publicado: (2015) -
Combination antifungal treatment in critically ill patients failing first-line therapy for invasive fungal infections
por: Pagani, L, et al.
Publicado: (2006)